Donald N. Forthal

11.0k total citations · 2 hit papers
100 papers, 6.3k citations indexed

About

Donald N. Forthal is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Donald N. Forthal has authored 100 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Virology, 50 papers in Immunology and 36 papers in Infectious Diseases. Recurrent topics in Donald N. Forthal's work include HIV Research and Treatment (51 papers), Immune Cell Function and Interaction (29 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). Donald N. Forthal is often cited by papers focused on HIV Research and Treatment (51 papers), Immune Cell Function and Interaction (29 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). Donald N. Forthal collaborates with scholars based in United States, France and Spain. Donald N. Forthal's co-authors include Gary Landucci, Dennis R. Burton, Ann J. Hessell, Youssef Rizk, John G. Rizk, Lars Hangartner, Carol A. Kemper, J. Allen McCutchan, Giuseppe Lippi and Brandon Michael Henry and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Donald N. Forthal

98 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fc receptor but not complement binding is important in antibody protection against HIV

2007 693 citations Ann J. Hessell, Gary Landucci et al. profile →
Prevention and Treatment of Monkeypox

2022 410 citations John G. Rizk, Donald N. Forthal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donald N. Forthal United States	38	3.5k	2.6k	2.3k	1.9k	1.3k	100	6.3k
Robert T. Bailer United States	42	2.7k 0.8×	2.5k 1.0×	2.5k 1.1×	1.6k 0.9×	1.4k 1.1×	79	5.9k
Georgia D. Tomaras United States	44	4.5k 1.3×	3.7k 1.4×	1.8k 0.8×	1.4k 0.7×	1.5k 1.2×	190	6.4k
Terri Wrin United States	49	7.5k 2.1×	2.7k 1.1×	5.0k 2.2×	1.3k 0.7×	1.5k 1.1×	102	8.4k
Paul A. Goepfert United States	45	4.1k 1.2×	3.8k 1.4×	2.0k 0.9×	1.7k 0.9×	1.4k 1.1×	144	6.9k
Gunnel Biberfeld Sweden	50	4.0k 1.1×	2.4k 0.9×	3.4k 1.5×	2.9k 1.6×	854 0.7×	275	8.2k
Hendrik Streeck United States	42	3.4k 1.0×	4.3k 1.7×	1.9k 0.9×	1.2k 0.7×	1.1k 0.8×	116	6.8k
J Michael Kilby United States	26	5.2k 1.5×	2.0k 0.8×	3.7k 1.6×	1.4k 0.8×	1.2k 1.0×	53	6.5k
Martha Nason United States	34	2.4k 0.7×	2.3k 0.9×	1.9k 0.9×	1.4k 0.7×	823 0.6×	85	5.1k
Shan Lu United States	40	1.9k 0.6×	2.4k 0.9×	1.7k 0.8×	1.6k 0.9×	1.6k 1.2×	168	5.3k
Nelson L. Michael United States	52	5.1k 1.5×	2.8k 1.1×	4.1k 1.8×	2.0k 1.1×	1.4k 1.0×	269	8.6k

Countries citing papers authored by Donald N. Forthal

Since Specialization

Citations

This map shows the geographic impact of Donald N. Forthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald N. Forthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald N. Forthal more than expected).

Fields of papers citing papers by Donald N. Forthal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald N. Forthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald N. Forthal. The network helps show where Donald N. Forthal may publish in the future.

Co-authorship network of co-authors of Donald N. Forthal

This figure shows the co-authorship network connecting the top 25 collaborators of Donald N. Forthal. A scholar is included among the top collaborators of Donald N. Forthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald N. Forthal. Donald N. Forthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rallón, Norma, José M. Benito, Francisco J. Márquez, et al.. (2024). Impact of Human Leukocyte Antigen Allele–Killer Cell Immunoglobulin-like Receptor Partners on Sexually Transmitted Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 230(5). e1077–e1081.

Chung, Jee Young, Melissa N. Thone, Johannes S. Gach, et al.. (2023). Vaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cells. Cellular Immunology. 386. 104691–104691. 4 indexed citations

Singh, Parvati, Donald N. Forthal, Manisha Shah, & Tim A. Bruckner. (2022). Association between vaccine preventable diseases in children and improved sanitation following a nationwide sanitation campaign in India: an ecological analysis. BMJ Open. 12(4). e052937–e052937. 2 indexed citations

Lee, Helen, et al.. (2021). 306. Association of Antibiotic Use and Development Secondary Infection from Clostridium difficile, Multidrug-Resistant Bacteria, and Candida in Hospitalized Patients with History of COVID-19. Open Forum Infectious Diseases. 8(Supplement_1). S259–S260.

Rizk, John G., Donald N. Forthal, Kamyar Kalantar‐Zadeh, et al.. (2020). Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.. Drug Discovery Today. 26(2). 593–603. 50 indexed citations

Gach, Johannes S., Marcus P. Wong, Veronika Chromikova, et al.. (2017). Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis. PLoS Pathogens. 13(12). e1006793–e1006793. 20 indexed citations

Loos, Andreas, Johannes S. Gach, Thomas Hackl, et al.. (2015). Glycan modulation and sulfoengineering of anti–HIV-1 monoclonal antibody PG9 in plants. Proceedings of the National Academy of Sciences. 112(41). 12675–12680. 36 indexed citations

Chromikova, Veronika, Stefan Hofbauer, Christoph Göbl, et al.. (2015). Introduction of germline residues improves the stability of anti-HIV mAb 2G12-IgM. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1854(10). 1536–1544. 6 indexed citations

Gach, Johannes S., Heribert Quendler, Tommy Tong, et al.. (2013). A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1. PLoS ONE. 8(8). e72054–e72054. 16 indexed citations

10.

McBurney, Sean P., Gary Landucci, Donald N. Forthal, & Ted M. Ross. (2012). Evaluation of Heterologous Vaginal SHIV SF162p4 Infection Following Vaccination with a Polyvalent Clade B Virus-Like Particle Vaccine. AIDS Research and Human Retroviruses. 28(9). 1063–1072. 5 indexed citations

11.

Hessell, Ann J., Eva G. Rakasz, David M. Tehrani, et al.. (2009). Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIV _Ba-L. Journal of Virology. 84(3). 1302–1313. 250 indexed citations

12.

Barouch, Dan H., Jinyan Liu, Diana M. Lynch, et al.. (2009). Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys. Journal of Virology. 83(18). 9584–9590. 26 indexed citations

13.

Miller, Christopher J., Meritxell Genescà, Kristina Abel, et al.. (2007). Antiviral Antibodies Are Necessary for Control of Simian Immunodeficiency Virus Replication. Journal of Virology. 81(10). 5024–5035. 64 indexed citations

14.

Forthal, Donald N., et al.. (2007). FcγRIIa Genotype Predicts Progression of HIV Infection. The Journal of Immunology. 179(11). 7916–7923. 109 indexed citations

15.

Florese, Ruth H., Koen K. A. Van Rompay, Donald N. Forthal, et al.. (2006). Evaluation of Passively Transferred, Nonneutralizing Antibody-Dependent Cellular Cytotoxicity-Mediating IgG in Protection of Neonatal Rhesus Macaques against Oral SIVmac251 Challenge. The Journal of Immunology. 177(6). 4028–4036. 63 indexed citations

16.

Forthal, Donald N.. (2005). Individuals Homozygous for the V Allele of FcγRIIIa May Have Increased Risk of HIV Infection Following Vaccination with Recombinant gp120. 1 indexed citations

17.

Forthal, Donald N., et al.. (2001). Relationship between Antibody-Dependent Cellular Cytotoxicity, Plasma HIV Type 1 RNA, and CD4 ⁺ Lymphocyte Count. AIDS Research and Human Retroviruses. 17(6). 553–561. 66 indexed citations

18.

Havlir, Diane V., Michael P. Dubé, J. Allen McCutchan, et al.. (1998). Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS. Clinical Infectious Diseases. 27(6). 1369–1375. 49 indexed citations

19.

Forthal, Donald N., et al.. (1994). Measles Virus-Specific Functional Antibody Responses and Viremia during Acute Measles. The Journal of Infectious Diseases. 169(6). 1377–1380. 24 indexed citations

20.

Larsen, Robert A., Samuel A. Bozzette, Brenda E. Jones, et al.. (1994). Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS. Clinical Infectious Diseases. 19(4). 741–745. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact